Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-123,500
Closed -$34.8M 1223
2025
Q3
$34.8M Buy
123,500
+52,800
+75% +$15.3M 0.64% 23
2025
Q2
$19.7M Buy
70,700
+32,400
+85% +$9.18M 0.45% 35
2025
Q1
$11.9M Buy
+38,300
New +$11.3M 0.33% 46

Other funds holding AMGN

DRW Securities's AMGN Position: Q1 2026 in Review

DRW Securities reduced its Amgen (AMGN) stake by 54% in Q1 2026, selling an estimated $314K and leaving 765 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

DRW Securities first reported a position in AMGN in Q4 2017 and has held it in 12 quarters since. The position peaked at $11.4M in Q3 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • DRW Securities held 765 shares of Amgen worth $266K as of Q1 2026.
  • DRW Securities sold 881 Amgen shares in Q1 2026, an estimated $314K.
  • Amgen made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #965 holding.
  • DRW Securities first reported a position in Amgen in Q4 2017 and has held it in 12 quarters since.
  • DRW Securities's Amgen position peaked at $11.4M in Q3 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.